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Introduction
Substandard, spurious, falsely labelled, falsified and counterfeit 
(SSFFC) medical products1 are each year becoming an increasing 
threat to consumers’ health and the problem remains largely 
underreported.2 SSFFC’s is a term defined by members of state which 
identifies the products associated with the illicit trade. Although 
there is currently no agreed definition, counterfeit medicines were 
previously defined by the World Health Organisation (WHO) as “one 
which is deliberately and fraudulently mislabelled with respect to 
identity and/or source. Counterfeiting can apply to both branded and 
generic products, and counterfeit products may include products with 
the correct ingredients or with the wrong ingredients, without active 
ingredients, with insufficient (inadequate quantities of ingredient(s), 
or with counterfeit packaging.3” It should be noted that counterfeit 
and substandard do not necessarily equate to the same meaning. 
Substandard purely refers to products being manufactured to a poorer 
quality than that which is established for effectiveness.4 There is a 
common misconception that the counterfeit market is only prevalent 
in poorer, developing countries, largely due to the lack of training 
and testing within their hospitals making them acutely vulnerable5 
however it is a worldwide problem. In the United Kingdom (UK) the 
size of the illegal drug market is unknown;6 it is reported to be far 
more common for ‘self enhancement’ products to be purchased online 
rather than antibiotics and vaccinations, however the sale of cancer 
and heart disease treatments are progressively rising.7,8 As recently 
as 2013, a south-west England city was under investigation for the 
purchase and supply of illicit steroids and other performance and 
image enhancing drugs (PIED).9 
History 
During the mid-19th century the adulteration of pharmaceuticals 
was prevalent in the UK and USA, with quinine being largely 
falsified.10 Although sophisticated drug counterfeiting is a relatively 
modern problem, general counterfeiting of goods, including currency, 
by criminal networks is a long-standing and deep-rooted issue. Ever 
since economic transactions started to be managed by market and 
currency systems, these groups have used illicit products to turn 
out profits and evade taxation.11 The widespread phenomenon that 
is counterfeit drug trafficking was first acknowledged as a problem 
by the WHO in 19858 with the issue first being discussed at length 
in 1998 at the World Health Assembly.12 Over the past two decades, 
the evidence supporting their claim has steadily increased13 with new 
cases being discovered weekly.14 When the issue was first brought to 
attention in developed countries, the counterfeit market tended to focus 
on expensive lifestyle drugs13 with the most commonly abused being 
sildenafil citrate, more commonly known as Viagra.15 As times have 
progressed, counterfeiters now tend to take advantage of whatever is 
in high demand, which currently has spread too anticancer, antivirals 
and diabetic medication.8 Although the UK does not tend to produce 
the illicit products, it is one of the many wealthy countries targeted by 
counterfeiters due to the vast potential for profit.16 The Medicines & 
Healthcare products Regulatory Agency (MHRA) have stated that the 
UK is being used as a “transit point, distribution hub and end-user” 
for these products.17 
Since late 1990s the sale of SSFFC’s through internet based 
pharmacies has been a recognised problem.18 Online criminals 
have anonymity, which gives them security whilst having access to 
the global consumer.19 Criminal activity around this area is highly 
attractive due to the low risk, high profit nature. Top priority action is 
not considered necessary by law enforcers, resulting in the penalties 
that the majority of countries give being far less severe than those 
of serious level crimes.20 Another appeal to modern organised crime 
groups is that logistically the distribution of the products is simple, 
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Abstract
Counterfeit pharmaceuticals are a serious and ever-growing threat to public safety. 
Monitoring the trade is difficult, resulting in the precise scale of the problem being 
unknown, however evidence shows that it is not just lifestyle drugs that are targeted 
nowadays. Adverse health problems, including fatalities, have resulted from consumers 
self-medicating with counterfeit products. Without efforts to enhance the public’s 
knowledge, the problem will continue to persist. The internet is facilitating the trade by 
providing counterfeiters with a large consumer base and limited risks. The dark net within 
it allows for anonymous transactions between manufacturer, distributer and consumer. 
While some online pharmacies are legitimate, there are a growing number of those that are 
unverified which sell dangerous counterfeit products. Both the packaging and medication 
are becoming increasingly sophisticated, making it difficult for consumers and law 
enforcement to identify them without chemical analysis. Counterfeit batches have also 
been detected in established legal trade routes whereby they are able to, if undetected, end 
up in high street pharmacies and hospitals. Multiple organisations have set up worldwide 
operations to dismantle the trade however this is a complex and evolving problem that 
without significant changes to legislation may never be fully 
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by abusing the existing legitimate supply chains (Figure 1). By 
exploiting this, the distribution is widespread, reliable and detection 
risk is limited.20 However for consumers this results in pharmacies and 
hospitals not always being considered safe.22 Counterfeiting appears 
across most therapeutic classes, with both branded and generic 
medicines being targeted22 along with medical products including 
syringes and medical equipment23 such as blood glucose test strips.24 
Local law enforcement tends to have little knowledge of the issue 
therefore allocating resources to help tackle the problem remain low 
priority.19 Due to this lack of awareness, consumers, who mostly do 
not think to question the authenticity of their medical products, are 
found to be at a disadvantage. 
Figure 1 Supply route of counterfeit drugs through legitimate supply chains.21
Scale of the problem
With global economy expansion and ease of access to the 
internet, a strong and secure foundation for counterfeit operations is 
now achievable.19 Despite quantifying the illicit goods trade being 
exceedingly challenging, in 2011 the World Economic Forum reported 
that it was thought to represent 7 – 10% of the global economy.25 
Pharmaceutical counterfeiting has shown an increase in recent years, 
with the whole world now being aware of the problem.14 Although 
the overall scope of the market remains unknown, it has been 
approximated that 10% of drugs sold worldwide are counterfeit,13 
with the prevalence of these drugs in certain areas of Africa and Asia 
believing to have reached 70%.26 Based on public sources, estimations 
of the market size were made, the results of this can be seen in Table 
1. Even though these are only rough approximations, it is evident 
that the counterfeit pharmaceutical market is thriving and seeming to 
bring in more profit than any one classic illicit drug. Without definite 
legislation being put in place, the figure of $200 billion per year 
is likely to continue to grow.25 The UK was found to be ranked 7th 
in a 2006 poll carried out by the Pharmaceutical Security Institute 
looking at the number of counterfeit drugs discovered and seized in 
countries worldwide.27 There are two main reasons as to why the UK 
is targeted, the first is due to the convenient location. Counterfeiters 
use the UK as a transit point from Asia to reach consumers based in 
the USA and Western European. The second is as an end user market; 
due to the increased prices and consumption seen here, the profits 
capable of being produced in the UK are huge.27 It remains highly 
concerning that there is a strong correlation between the increase 
sale and distribution of counterfeit drugs and the growth of microbial 
resistance. This will in due course lead to increase costs and further 
strain on the healthcare system18,26 and potentially result in lifesaving 
medicines becoming ineffective.
Table 1 Estimated market size of illicit goods represented in USD billion per 
year25
Illicit Good Estimated annual market size (USD billion)
Counterfeit pharmaceutical drugs 200
Prostitution 190
Marijuana 140
Counterfeit electronics 100
Cocaine 80
Opium and heroin 60
Web video piracy 60
Software piracy 50
Cigarette smuggling 50
Human trafficking 30
Environmental crimes and natural 
resources trade 
20
Logging 5
Art and cultural artefacts 5
Small arms 1
Serious security issues arise from importation and re-importation 
as this allows for counterfeit batches to more easily enter the countries 
legitimate supply chain. They can then be distributed to pharmacies 
and hospitals who unknowingly then supply them to patients.13 In 
2005 the U.S. Food and Drug Administration (FDA) were required 
to recall a counterfeit batch of “Lipitor”, an atorvastatin used to 
treat high cholesterol, that had been sold into the UK.28 Due to the 
counterfeit product being distributed, there were worries as to its 
quality and effectiveness. After initial investigations it was found to 
not pose an immediate health risk however patients were still advised 
to stop taking the drug and return it to the establishment they had 
received it from. Although in this case the counterfeit Lipitor did not 
cause adverse effects to health, it did result in a decline in consumer 
confidence in the genuine product and the pharmacy that supplied 
them with it.17
Organised crime
With relatively low risk for high profits compared to cocaine, 
crack or heroin; it is hardly surprising that organised criminal groups 
have taken an interest in the counterfeit licit drug trade.29 Pfizer, 
the pharmaceutical company that manufacture and license Viagra, 
compared the profitability of Viagra to heroin. They found that 1kg 
of heroin had higher production costs with lower street value than 
the same quantity of Viagra. The MHRA investigated a case whereby 
100,000 counterfeit Viagra pills were imported into the UK from a 
Chinese manufacturer at approximately 25 pence each with a resale 
value of up to £20 each, resulting in a profit of £1.6 million.30 Criminal 
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gangs including the Russian mafia, Colombian drug cartels, Chinese 
triads and Mexican drug gangs21 have become involved in the trade, 
so much so that now organised crime is largely responsible for the 
entire market.31 With large networks and vast resources32 they are able 
to maintain complex structures over long periods of time and avoid 
additional costs by using already existing trafficking routes,31 making 
this a far more sophisticated issue. Further evidence is present that 
establishes connections between pharmaceutical counterfeiting and 
illicit drug production, trafficking and money laundering.31 In 2008, 
Canadian police reported seizing ecstasy and methamphetamine pills 
alongside counterfeit Viagra and Cialis tablets.31 In addition to this, 
increasing evidence highlights the involvement of Hezbollah and al 
Qaeda21 who are using the profits to fund terrorist activities.22 This 
was brought to light in 2006 when 19 individuals, who were running 
a terrorist ring, were charged after selling counterfeit drugs and other 
contraband to support the activities of Hezbollah.29,33
Dangers of SSFFC medicines 
Prescription drug abuse has been described as “second only to 
marijuana abuse” with the user achieving a false sense of security 
due to them being FDA approved,34 however consumers who purchase 
from illicit sources face devastating health and safety risks. Not only 
does the consumer suffer due to the sale of SSFFC’s but so does 
the economy, as the counterfeit market reduces the profits made by 
legitimate drug companies.35 Despite governments worldwide facing 
tax revenue losses, budget is having to be allocated in attempts to tackle 
the problem.19 Annually it is estimated that over half a million deaths 
are caused directly by counterfeit medicines.30 The exact number who 
have suffered or died, however, is not easily distinguishable due to 
direct links not always being evident and in many case people are not 
aware they have taken falsified medication.26 A UK based survey of 
general practitioners found that 25% had been required to treat patients 
who were suffering side effects from drugs they had purchased online.26 
Particular concern arises when counterfeiters reduce the quantity of 
active ingredients present within the medication,4 often leading to the 
addition of an undeclared lethal active ingredient as an alternative.36 
If an unknown is added consumers are at risk of serious harm as they 
are unaware of what they are ingesting. This became evident at a 
children’s hospital in Bangladesh where in excess of 400 children lost 
their lives after being administered an adulterated paracetamol which 
lead to renal failure.37 Potentially even more dangerous and indirectly 
causing more deaths annually than once thought, is that with a lower 
concentration of active ingredients, consumers with life threatening 
illnesses may think they are treating the disease only to discover that 
the medication is not working in the desired way.
There is always concern with unregulated medications as good 
manufacturing practice is not necessarily preformed during production. 
In the UK anabolic-androgenic steroids (AAS) are controlled under 
the Misuse of Drugs Act, Schedule 4, Part 2. Classified as a class C, 
it is an offence to sell or supply steroids and to possess them without 
a prescription.38 Despite the UK having legislation controlling 
AAS use in competitive sport, this has not stopped the distribution 
online or via the black market. UK females are increasingly abusing 
recombinant human growth hormone (rhGH) in the form of intra-
muscular injections.39 Due to non-sterilised counterfeit products 
being purchased there has been a spike in the number of cases of intra-
muscular abscesses, as shown in Figure 2. In 2009, the World Anti-
Doping Agency (WADA) investigated 57 tablets to identify the degree 
to which counterfeit products were accessible. It was determined 
that 42% of those tested were counterfeit, either containing different 
steroids to what was declared or none at all. 
Figure 2 Intra-muscular abscess of the right bicep.39
The degree to which the internet has assisted 
counterfeiters
Living in a dynamic world with the global consumer having 
continual access to broadband40 it is hardly surprising that online drug 
markets have vastly grown in popularity when compared to local 
community pharmacies. 1999 showed rise to the first exclusively online 
pharmacy in Europe41 and in the same year came the first case of online 
distribution to make headlines. Dr Pasos, an orthopaedic surgeon, 
was accused of unprofessional conduct after prescribing Viagra to a 
Russian sailor who was in the Atlantic at the time.42 In general terms 
an online pharmacy (OP) is an organisation that allows consumers 
to purchase pharmaceuticals, including prescription-only medication, 
via an online ordering and mail delivery system.18 Legitimate OPs 
will request registration and card payment information as well as 
requesting that a prescription be sent, usually by post, before the order 
will be shipped.7 Without a valid prescription, signed by a doctor, the 
supply of these medications is illegal. More commonly referred to as 
the dark net, The Onion Router (TOR) network is an encrypted area of 
the internet allowing for anonymous communications with no trace of 
website history or physical location.43 This is an easily accessible and 
private means for accessing drugs across the border. However, with 
few OPs based in Europe,41 partial regulation and varying legislation 
depending on where in the world the company is based, it has become 
an almost ‘safe’ place for counterfeiters to operate. Internet security 
experts estimate that 15 billion30 spam emails advertising the services 
of these websites are sent each day and reach virtually everyone in 
Europe. It is likely that the majority of sites accessed through this 
method are counterfeit. For most, these emails are seen as no more 
than an irritation that are swiftly sent to the junk folder, but even if 
only a minor proportion of individuals react and purchase the products 
on offer, this could easily account for tens of thousands of sales each 
day.7 
The virtual interface 
The internet has greatly increased the complexity of the counterfeit 
drug trade22 and one fact is certain, the safety of these OPs is highly 
associated with geographical location. “Brick-and-mortar” OPs tend 
to be an extension of a high street pharmacy that can be visited by 
customers.44 The questionable safety of buying online tends to be 
when the business exists purely in cyberspace. They tend to be lightly 
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monitored and work largely outside the law.45 In a sample population of 
118 OPs more than half (56.8%) only had a virtual interface, however 
of those that did give a geographical location only in 54.9% of the 
sites did this location match the area of domain registration.46 Illicit 
marketing has also seen a shift from designated internet search engine 
websites to advertising on multiple social media websites.47 This sets 
to escalate the number of individuals who are likely to see the adverts 
and use these OPs. This also offers counterfeiters an increase reach to 
a younger and more vulnerable consumer base.
The appeal of online counterfeiting 
The pharmaceutical industry is one of the largest in the world 
and where demand is present there are criminals willing to take 
advantage. The internet has simplified the drug trade and allows for 
a wider customer base to be established.27 With low production costs, 
the profit margin on illicit pharmaceuticals is huge. World Finance32 
estimates that, in excess of 800 pharmaceuticals have counterfeit 
versions in circulation globally. They estimate that in developing 
countries, such as India or China, Viagra can be purchased for $60/
kg and when transformed into 25mg tablets, can be sold for $200,000. 
Some counterfeiters add cutting agents prior to the tablets being 
formed, this will increase the product that is available for sale which 
is an attraction for the producer as a higher income will be achieved, 
but a problem for consumer due to reductions in the declared active 
ingredient present. The appeal of this highly profitable business is 
heightened by the ineffective legislation that is present in the UK. The 
current legal framework allows the MHRA to prosecute those who 
produce and distribute counterfeit products within the UK, however 
the law also allows for individuals to import products for personal 
use, providing they are licenced in this country.16 These products can 
be ordered online from countries that do not comply with the same 
quality control standards as expected in the UK. Selling counterfeit 
medicines is currently regulated under intellectual property crime and 
infringement.48 These lax laws allow counterfeiters to receive lighter 
punishments than those given to criminals who supply classic illicit 
drugs,49 despite the dangers to consumers being just as high.
Who uses these sites?
John Clark, leader of Pfizer’s Global Security team estimates that 
in the UK 2 million people buy prescription medication online.26 
In 2009, a UK based survey of 2076 adults carried out by the 
MHRA into bypassing the healthcare system revealed that 15% had 
purchased medical products online without a prescription.50 Internet 
pharmacies offer an attractive appeal to various patient populations. 
There are those that, despite valuing the consultations received by 
healthcare professionals, find the lower prices or ease of access the 
internet offers too enticing. This is especially true for those who are 
financially strained or with limited mobility, including the disabled 
and elderly, where accessing doctor surgeries may cause difficulties. 
The main groups that counterfeiters thrive off however, are those 
individuals looking to avoid the doctors and the healthcare systems 
altogether.51 These may be individuals looking for lifestyle drugs due 
to conditions including obesity, hair loss and male impotence which 
cause embarrassment, or drug addicts looking for their fixes in a more 
secretive way. Both will be far less likely to confide in a doctor if 
problems arise, instead tending to purchase a new online. Tramadol, 
amphetamine, methamphetamine and codeine, all drugs that have an 
inherent risk of being dangerous to health and strongly addictive, are 
facilitating abuse by being readily available online.46
Requirement of prescription 
The sale of controlled substances without a valid prescription is 
illegal in the UK due to consumers not having the required knowledge 
to competently medicate themselves. Prescriptions permit for follow 
up sessions with the prescribing medical practitioner to ensure the 
drug is having the required effect and therefore allowing quality 
standards to be upheld.18 In the case of certain OPs, rather that asking 
for a prescription the website will take the consumer through an online 
questionnaire that aims to evaluate their health status. No standardised 
test exists, so the competency of this method is questionable. In a 2007 
study46 it was found that only 18.6% of the 118 sample population of 
OPs asked for a valid prescription signed by a physician. Of the 81.4% 
that did not request this, 68.8% required their customers to fill out 
a medical questionnaire. The remaining 31.6% did not require any 
information in order to make a purchase. Orizio et al.52 investigated 
57 OPs in 2009 that use these questionnaires. They reported that 
many were already completed with negative answers prior to starting 
and that they could, in most cases, be submitted incomplete. It was 
concluded that the presence of these tests was more likely to give 
the consumer a sense of security rather than an actual assessment 
of health. It has also been seen that those who do not require a 
prescription or offer online consultations attempt to create an image 
of transparency and honesty, often achieved by giving comprehensive 
information about the online transaction system, security of payment, 
and origin of drugs.53 Although it is known from other studies that this 
is not always accurate 
Advertising strategies
OPs tend to amplify the aspects that will appeal to consumers 
while overshadowing the risks and dangers behind the products.54 
Orizio et al.46 compared the promotion of drugs between pharmacies 
that require a prescription and those that do not. Illustrated in Figure 3, 
it is clearly seen that those which do not require a prescription, use far 
more advertising strategies, including the idea that patients can avoid 
seeing a physician. This confidentiality that buying online offers is one 
of the key selling techniques; boasting advantages of not only avoiding 
medical professionals but with discreet packaging, no one needs to 
be aware of what you are taking.18 The lower price associated with 
buying online is a major appeal to many consumers, however it is not 
always as good value as it may seem on the surface. As determined by 
Levaggi,55 consumers buying drugs without a prescription spent more 
than those who did and that in order to achieve the cheaper pricing it 
was required that items be bought in higher quantities, this was also 
found by Armstrong.56 In order to promote bulk purchases a reduced 
number of side effects tend to be declared, that way encouraging the 
consumer to believe that prolonged exposure to the drug will only be 
advantageous to their life.55 
Packaging 
Consumers and authorities are finding it increasing difficult to 
identify illicit versions of medication through visual inspection 
alone.24 Despite the legitimate pharmaceutical industry consistently 
implementing new measures to help to protect genuine products and 
allow for easier distinction from counterfeit products,14 criminals are 
able to quickly adapt to these modifications with the help of rapidly 
enhancing technology.4 As shown in Figure 4, technological advances 
have greatly enhanced counterfeiters’ ability to create packaging that 
is exceptionally close to the drugs authentic packaging.4 Criminals 
are becoming increasingly able to mimic logos using colour shifting 
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inks and holographs.57 Tools, including 3D printers, are becoming 
progressively more common as a production method for components 
of, or entire packaging.19
Figure 3 Common selling arguments used by OPs.46
Figure 4 Counterfeit packaging recovered during Operation Zambezi in 
2009.12
Health information 
The disclosure of health information and side effects appears to 
remain highly varied across OPs with no consistency between those 
websites that require prescriptions and those that do not. Sildenafil, 
fluoxetine, tramadol and amitriptyline are widely available and 
popular drugs within the online market. When side effect disclosure 
was investigated for these drugs, a quarter of the 118 sample sites did 
not offer any form of statement.46 Of that sample, when compared 
against prescription OPs, non-prescription OPs showed a higher 
number of declarations for fluoxetine and amitriptyline, no significant 
difference for tramadol, but sildenafil was described as having far 
fewer risks. The same conclusion of results was found in another 
sample, this time of 161 OPs, where no declarations were found in a 
third of those investigated. Regarding the lifestyle drug, sildenafil, it 
was again found that a far lower proportion of non-prescription OPs 
declared side-effects compared to prescription OPs,54 highlighting 
the idea that this is likely done intentionally due to the high profit 
capability of this drug.18 
Delivery into the UK 
Geographically diverse supply chains have resulted in counterfeit 
operations being possible at any step within the supply chain in 
whichever country that operation may be based.58 With the exception 
of small scale operations, illicit pharmaceuticals are not produced in 
the UK. They are more often imported through a range of trade routes; 
the widest known production countries are China and Russia, with 
India and Pakistan becoming increasingly common.27 It is recognised 
that a common technique used by criminals for the importation of 
counterfeit batches is to take advantage of supply routes that are 
already operational. Known as parallel trading, private traders within 
the European Union are able to legally purchase large quantities of 
pharmaceuticals in Member States at lower prices and then sell them in 
higher-priced Member States for a profit.27,59 The exportation countries 
experience shortages hence allowing falsified medications to be sold 
in order to fill the demand. Before re-sale, the licit pharmaceuticals are 
often re-packaged in order to help them sell in that particular country, 
but again this leaves them exposed to criminals who use this practice to 
disguise counterfeit batches and enter them into the legitimate supply 
chain.59 It is not unheard of though for OPs to operate out of normal 
suburban areas, an example of this was in 2008. A house in the East 
Midlands was under investigation by the MHRA and subsequently 
raided for being the physical location of an OP that was supposedly 
based in the USA. Prior to the raid, an intelligence officer on the case 
had successfully bought an Indian version of Viagra, which is illegal 
in the UK.30 Another instance that saw the UK being implicated in the 
trade was when the avian influenza (bird-flu) virus was at its peak. 
The MHRA detected multiple versions of the antiviral drug Tamiflu 
for sale from eighteen illegal OPs, three of which were based in the 
UK.60 The drug was found to contain no active ingredient with the 
bulk of the composition being made up of vitamin C. 
What threats are posed?
Ongoing development of internet pharmacies has seen doctor-
patient relationships suffer and as “patient empowerment” grows,55 
self-medication is becoming a serious risk to public safety. Even 
when a drug is legitimate, without regulation harmful side effects 
can occur. Serious cases have been reported whereby adverse effects 
caused by self-medication have resulted in consumers turning back 
to medical professionals. In the long term this will cause damaging 
effects to the healthcare system as it is likely that an increase amount 
of prescriptions will have to be handed out in comparison to what 
would have been initially required. Not only will the side effects 
require treatment but the original problem will still be present. This 
is particularly true with prescription drug addicts, who often abuse 
opiates intended for pain relief. Whereas they used to have to visit 
multiple doctors in order to receive valid prescriptions, they are 
now able to avoid this step and anonymously buy these controlled 
substances online.45 It is not uncommon for consumers to continue 
to take adulterated medication despite symptoms being evident. One 
example of this was in 2006 where a 58-year-old Canadian woman 
died of metal toxicity after months of taking a sedative that she bought 
online, despite experiencing many side effects including hair loss and 
distorted vision.61 On examination by the FDA the likely cause of the 
metal contamination was due to the cutting agents used within the 
manufacturer of the pills. Not only are consumers putting their health 
at risk, they are vulnerable to becoming preyed on financially due to 
submitting their payment card information onto illegitimate sites.51 
Many different forms on contraception are available online without the 
requirement of a prescription and the women who buy these products 
are putting themselves at serious risk.62 Not only are counterfeits a 
danger but there are many known side effects that can vary significantly 
depending on the woman’s health and should be carefully monitored 
by a physician. Without this professional guidance, not only is safety 
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disregarded but a lack of education into the area persists, which is 
particularly concerning for younger generations. A study investigated 
the availability of these products to low and high risk individuals by 
purchasing through different aliases.47 It was found that regardless 
of individual, all medication could be obtained without the need of 
prescription, despite questionnaires being present that required the 
consumer to enter information including their blood pressure, age and 
weight. 
Action and the way forward 
Organisations
Strained resources and implications of ethics, including patient 
privacy, have limited the efforts to tackle this consistently growing 
and evolving issue.35 The International Criminal Police Organisation 
(INTERPOL) have undertaken multiple large scale operations in order 
to tackle pharmaceutical crime but have confirmed that there is a vital 
need for continued intervention.63 Operation Pangea, launched in 2008, 
was the first of its kind dealing with targeting internet pharmacies on 
an international scale.64 To date it has gained a significant following 
and is active in over 100 countries.58 Operation Mamba followed, 
with the goal being to intercept the trafficking activities of counterfeit 
medical products in Eastern Africa before they could reach developed 
countries whilst raising awareness.65 The MHRA launched a three-
pronged strategy in the same year, as summarised in Table 2, to tackle 
the problem.17 Success of this strategy was found to be problematic 
to quantify as the initial scale was unknown and hence the level 
of risk to consumers remains undetermined. To attempt to create 
solidarity worldwide, the WHO launched the Global Surveillance and 
Monitoring System for SSFFC medical products in 2013. To date 113 
countries have joined forces with the combined aim to:1 
Table 2 Summary of MHRA three-pronged strategy to combat counterfeiting17 
Method Key Aims
Communication 
To provide the public with enough accurate information 
in a timely manner to provide reassurance and allow 
them to make informed choices when obtaining 
medication and medical products.
Collaboration
To develop and maintain a working relationship with 
both industry and law enforcement to devise a list of 
medication and medical products that at a high risk of 
being counterfeited and targeted in the UK and focus 
resources on these throughout the supply chain.
Encourage reporting of all suspect medicine and 
medical products and refer to the MHRA for 
investigation. 
Improve and expand the target market surveillance 
scheme.
Ensure the strategic threat assessment of the availability 
of counterfeit medicines and medical products in the 
UK is consistently updated and accurate.  
 Work alongside the WHO and other international 
organisations to combat the threat of counterfeit 
medicines and medical products. 
Regulation 
Shift the counterfeit market so that there is an increased 
risk of prosecution in the UK. 
Identify the key players within criminal gangs that 
operate the counterfeit market.
Bring about changes in both UK based and international 
legislation so there is an increased risk associated with 
counterfeiting and therefore a reduction in the market.
“Provide technical support in emergencies, link incidents between 
countries and regions, and issue WHO medical product alerts; 
and accumulate a validated body of evidence to more accurately 
demonstrate the scope, scale, harm caused by SSFFC medical 
products and identify the vulnerabilities, weaknesses and trends.”
Online
The Partnership for Safe Medicines (PSM) has been working with 
online search engines to try to restrict advertising from unverified 
OPs.66 The organisation is attempting to create a uniform set of 
standards for paid advertising that will strive to ultimately eliminate 
unknowing customers purchasing products through illegitimate sites. 
The Royal Pharmaceutical Society of Great Britain (RPSGB) have 
implemented an internet pharmacy logo that aims to allow consumers 
to distinguish between genuine and counterfeit traders.7 Each logo 
has a unique number registered to a certain pharmacy (Figure 5); 
when clicked the RPSGB link you are directed to should match the 
number presented on the logo. From here, the consumer can check 
the records and authenticity of that provider. This, in theory, is a 
sensible safeguarding idea but the reality is that criminals will be able 
to recreate this logo and link to a standard that appears legitimate. 
The knowledge of this logo is also limited, with many consumers not 
understanding the significance. 
Figure 5 RSPGB logo given to genuine OPs, each having a unique number.7
Chemical and visual
Making dugs harder to duplicate has been a key focus of many 
pharmaceutical companies in recent years. Investigation into a covert 
or ‘invisible’ approach is underway whereby trace amounts of an 
inactive ingredient is added. This is known as a taggant and their aim is 
to allow for product authentication and easier detection of counterfeit 
products.67 In addition to chemical tracing, implementations need to 
be in place for tracking licit batches so that it is easier to identify if 
an illicit batch has been introduced into the supply chain. Holograms 
and concealed codes on the tablets themselves have been suggested 
but it is radio frequency identification (for whole batches) and two-
dimensional bar codes (for individual packets) that show the most 
promise.35 The idea being that each manufacturer would have a unique 
identification code that remained the same between countries, that 
way unknown codes will highlight the presence of illicit batches.68–70 
Conclusion 
Dismantling the counterfeit market remains a challenge and despite 
more investigations and spot checks being undertaken, it is a complex 
market with grey areas that remain ambiguous to officials.22 Bryan 
Liang, the PSM Vice President and Executive Director of the Institute 
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of Health Law Studies, recognised that the efforts to eliminate the 
counterfeit drug market are a long way from complete. In a 2010 
statement he explained that “new legislation that prohibits financial 
transactions for drug sales of unlicensed pharmacies and creates 
criminal penalties for websites, search engines and individuals who 
participate in the sale of contraband or counterfeit drugs” needs to 
be implemented worldwide.66 International collaboration is required 
with particular emphasis on the legal, forensic and scientific sectors.22 
Whenever counterfeit products are seized they should be examined 
from a forensic intelligence perspective, with all data obtained being 
stored into a database which will help law enforcement tackle illicit 
manufacture and trafficking of these items.14 The chemical profile 
should be mapped along with a general physical examination of the 
medication and packaging. Batch numbers, best before dates and 
any other relevant information should be entered which, after time, 
will allow for quick searching of seized products against known 
counterfeit batches. This information could further be mapped to 
provide statistics on the production and distribution within the 
network and allow calculated attempts to dismantle the problem from 
the source to be made. 
Although many international efforts are being made to reduce the 
trade, aggressive steps need to be taken to provide the public with 
a strong education campaign, as they are the final line of defence 
against these products. Consumers need to be aware of the frequency 
at which they circulate and if buying them willingly, they need to 
understand the severity of the possible health risks they are subjecting 
themselves and potentially their loved ones to.24 However, when 
involving the public, a balance needs to be found so as to not cause 
unnecessary panic surrounding this sensitive area. The information 
provided should be clear and insightful about the existence of 
counterfeit pharmaceuticals and what to do if they suspect they have 
been given one. It should also be made explicit that the individual risk 
is low and to not to lose faith in all local pharmacies.17 Pharmaceutical 
organisations should take a proactive approach by keeping in touch 
with their customers. The sale of all drugs manufactured should 
be tracked so that suspect counterfeit medication can be identified 
by unexplained drop of sales in a specific region or by an increase 
number of consumers complaining of an unexplained side effect.58 
The sad truth is that counterfeit medications may always be a problem 
and multidimensional efforts are needed across a range of industry 
sectors. Batches of legitimate medication must be tracked from 
production; however it is not sufficient to limit this to the packaging, 
a method to track the products themselves must be produced.33 The 
punishments received need to increase in severity but this will only 
help combat the issue when paired with robust enforcement, as an 
increase likelihood of being prosecuted and convicted needs to be 
present.29 Counterfeiters will always look for vulnerable targets to 
make quick profits from, but with increased global collaboration, new 
technologies and punishments that outweigh the perceived benefits,58 
the level of the crime will decrease. 
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